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Chagas Disease: A Dangerous Kiss
Stephen Maynard, RN, BA
Otterbein University, Westerville, Ohio
Introduction
Parasitic infections are a common
occurrence worldwide and are often more
common in low income countries. While
these infections are associated with poor
compromised communities outside the
United States these diseases effect people
within the United States and are more
common than realized. One specific
parasitic infection infects its human host
causing Chagas disease. Chagas disease is
an infection that occurs from the parasite T.
cruzi and was named for the Brazilian
physician Carlos Chagas who discovered
the disease in 1909 (CDC, 2014).
According to the Centers for Disease
Control (CDC, 2014), Chagas disease has
been targeted as a priority for public health
action, and is considered one of the
neglected parasitic infections. The CDC
(2014) considers Chagas disease a priority
due to its severity, the number of people
infected, and the ability to prevent and treat
the disease. According to Stampert and
Montgomery (2010), there is a substantial
knowledge deficit among physicians about
Chagas disease. This is concerning when
one considers the harmful effects of the
disease and the amount of people infected in
the United States. Chagas disease can be
acquired in the United States as there have
been cases of T. cruzi vector borne
infections in Mississippi (Canty et. al.,
2012).

Pathophysiological Processes
Chagas disease is transmitted when the
parasite T. cruzi enters the body. This
entry is done through the triatomine insect
also known as the “kissing bug”, which
hosts the parasite T. cruzi (CDC, 2014).
The parasites main mode of transmission is
through defecation of feces from the
triatomine bug to its human host. Being a
vector borne disease, it can also be
transmitted through food and drink infected
by T. cruzi. The disease may also be
transmitted congenitally, through blood
transfusions, or organ transplants
(Montgomery, Starr, Canty, Edwards, &
Meymandi, 2014). In the human host the
acute phase of T. cruzi is replicated in most
nucleated cell types. The T. cruzi will
activate cell signaling pathways used
during invasion of the human host cells.
During the chronic phase of the disease, the
T. cruzi parasite will primarily live in
cardiac and smooth muscle cells. T. cruzi
can cause hypertrophy, inflammation, and
fibrosis, in the cell, which can lead to heart
failure and gastrointestinal disorders (Mott,
Lenormand, Costales, Fredberg, &
Burleigh, 2009).

Currently there are more than 300,000
individuals infected with Chagas disease in
the United States (Woodhall, Jones, Cantey,
Wilkins, & Montgomery, 2014). The disease
is an endemic across Central and South
America, but the parasite that carries the
illness has been found in the United States
and there have been documented cases of
vector-borne infection in the United States
(Woodhall, et al., 2014). The disease will
persist for the life of the patient unless
treatment is initiated. If left alone the disease
has potential life threatening effects including
apical aneurysm, heart failure, megacolon,
megaesophagus, and the risk of stroke is
increased (Woodhall, et al., 2014). The
disease also carries potential congenital
effects including hepatosplenomegaly,
anemia, or thrombocytopenia. Treatment is
indicated for Chagis disease in patients
younger than 18 and for most adults younger
than 50 who do not have cardiomyopathy.
Drugs used to treat Chagas disease are not
approved by the Food and Drug
Administration but are available through the
CDC (Woodhall, et al., 2014).

Case Study
A 53 year old female presents to the emergency department with complaints of left
eye pain, headaches, daily fevers up to 102°F, dyspnea on exertion, decreased energy,
decreased appetite, and a blotchy rash. The patient had just recently returned from a
three week stay in Costa Rica. The patient stayed in a small village in Costa Rica that did
not have netting to cover the windows and bed. The patient did not have any symptoms
until 2 days after her return to the United States. Initially the patient was seen for left eye
swelling and pain and was treated for conjunctivitis and an allergic reaction. The patient
did not respond to these treatments, which prompted a referral to the emergency
department. Upon physical exam at the emergency department the patient vital signs
were all within normal limits, temperature 37.1°C, heart rate 91 beats/min, blood pressure
98/62 mmHg, respiratory rate 18 breaths/min, and oxygen saturation 98% on room air.
The patient was in no apparent distress. There was periorbital edema and mild erythema
of the left eye without visible discharge. The right eye was normal. All other physical
examinations were unremarkable (Carter, Juliano, Montgomery, & Qvarnstrom, 2012).

Above: Swelling of one eyelid called Romaña sign is a indicator of Acute Chagas
disease
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Above: The triatomine, the vector for the T. cruzi parasite. Copyright 2014 by CDC

Left and Right: The parasite T.
Cruzi in peripheral blood smears
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Diagnostic test for the patient were done and results were as follows. The patient
had an abnormal 12-lead echocardiogram (EKG) revealing sinus rhythm with a low
voltage QRS complex. In response to the abnormal EKG a transthoracic
echocardiogram (TTE) was performed. The TTE showed normal left ventricular
ejection fraction (60%), but noted diastolic left ventricular dysfunction, elevated left
ventricular filling pressure, dilated left atrium, thickened pericardium, and a small
circumferential pericardial effusion. Peripheral blood smear showed trypomastigotes of
T. cruzi. This finding was confirmed by the CDC, Parasitic Diseases Branch. All other
lab values were unremarkable. (Carter, Juliano, Montgomery, & Qvarnstrom, 2012).
The patient was treated for Chagas disease using CDC recommendations and the
patient returned to normal function including the function of the left ventricle (Carter,
Juliano, Montgomery, & Qvarnstrom, 2012).

Signs and Symptoms
When discussing signs and symptoms of Chagas disease we look at the two phases
the disease occurs in, acute and chronic. In the acute phase of Chagas disease caused by
T. cruzi symptoms are mild and often not seen. Symptoms include fever, headache,
enlarged lymph glands, difficulty breathing, chest pain, and abdominal pain. Some
individuals have a purple swelling to the lid of one eye, called Romaña sign, after the
initial bite from the triatomine bug (Chagas disease, 2010). In the chronic phase
symptoms include gastrointestinal problems and cardiac symptoms. The majority of
individuals with chronic Chagas disease will present with cardiac symptoms as the
disease process attacks cardiac muscle leading to heart failure (Chagas disease, 2010).

Nursing Implications
It is important for healthcare professionals practicing in different levels to be aware
of Chagas disease. Awareness of the disease is important because of the number of
infected individuals in the United States and the substantial knowledge deficit among
physicians Chagas disease (Stampert and Montgomery, 2010). Understanding at risk
populations, immigrants from areas where Chagas disease is endemic, individuals who
have traveled to those areas, and areas of poor sanitation here in the United States, can
help the healthcare provider recognize Chagas disease and limit the diseases impact on
patients. In catching and treating the disease in the acute phase long term effects of
chronic Chagas disease can be prevented. Chagas disease has been responsible for
30,000 to 45,000 prevalent cases of cardiomyopathy leading to heart failure (Custer et
al, 2012)..
It is also important to recognize the risk posed to the population through donations
of blood and solid organs. Blood is now being tested for T. cruzi and the testing has
been shown to be effective in recognizing the disease. Each donor is tested a single
time this process has been shown to decrease the risk of donor derived T. cruzi
infection (Custer et al, 2012). Individuals who test positive are referred to a physician
for further evaluation and treatment as the test is not confirmatory for the disease
(Custer et al, 2012). The risk of transmission through organ transmission is low but
does exist. In a 2013 study it was shown that only 19 percent of US organ procurement
organizations test for T. cruzi (Huprikar et al, 2013). Understanding at risk individuals
who are potential donors may help to increase the number of organs tested for T. cruzi.
Individuals may still receive organs from donors infected with T. cruzi but need to be
monitored closely for effects of Chagas disease (Huprikar et al, 2013).
The public needs to be made aware of diseases such as Chagas disease. This is the
responsibility of healthcare providers of all levels. Individuals leaving the country and
traveling to areas where Chagas disease is endemic need to be educated on signs and
symptoms and methods of prevention. If these individuals become infected by T. cruzi
they will hopefully understand signs and symptoms and not let acute Chagas disease
develop into the chronic form.

Conclusion
Chagas disease represents a burden to the United States health system with over
300,000 individuals being infected (Woodhall et al, 2014). The disease presents
severe complications if left untreated. The CDC list Chagas disease as a priority for
public health action (CDC, 2014). The designation of being a priority for action
implies that we as healthcare professionals need to understand and learn about the
disease its processes and risk factors. In doing this we can positively impact the lives
of those infected with Chagas disease and prevent long term complications.
Understanding diseases such as these are important as the world we live in becomes
smaller.
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